Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CFTX-1554 by Eli Lilly and Co for Neuropathic Pain (Neuralgia): Likelihood of Approval
CFTX-1554 is under clinical development by Eli Lilly and Co and currently in Phase I for Neuropathic Pain (Neuralgia). According...